Klogene Therapeutics, Inc.
PrivateCompany Overview
Klogene Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. It was founded in 2015.
Klogene Therapeutics, Inc. is a biotechnology company that develops novel neuroprotective therapeutics for neurodegenerative diseases by modulating the expression of the Klotho protein.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Klogene Therapeutics, Inc. Comparables
Compare Klogene Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jocasta Neuroscience | 88% | |
| ADvantage Therapeutics Inc. | 86% | |
| Klotho Neurosciences, Inc. | 84% |
For institutional investors. Book with your work email.
Klogene Therapeutics, Inc. Funding Rounds
Historical fundraising activity
Klogene Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Klogene Therapeutics, Inc.'s valuation, stock price, and market status.
Is Klogene Therapeutics, Inc. a public or private company?
Klogene Therapeutics, Inc. is a private company.
What is the current stock price of Klogene Therapeutics, Inc.?
Klogene Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Klogene Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Klogene Therapeutics, Inc. worth (valuation)?
Valuation information for Klogene Therapeutics, Inc. is not publicly available.
Can I buy Klogene Therapeutics, Inc. stock?
Klogene Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Klogene Therapeutics, Inc.'s last funding round?
Funding round information for Klogene Therapeutics, Inc. is not publicly available.
Who are the main investors in Klogene Therapeutics, Inc.?
Investor information for Klogene Therapeutics, Inc. is not publicly disclosed.
Will Klogene Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Klogene Therapeutics, Inc..
How can I track Klogene Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Klogene Therapeutics, Inc.'s shares on secondary markets.